rs2275029

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000350.3(ABCA4):ā€‹c.5844A>Gā€‹(p.Pro1948=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 1,611,868 control chromosomes in the GnomAD database, including 27,055 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.19 ( 2911 hom., cov: 32)
Exomes š‘“: 0.18 ( 24144 hom. )

Consequence

ABCA4
NM_000350.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:20O:1

Conservation

PhyloP100: -0.193
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 1-94008289-T-C is Benign according to our data. Variant chr1-94008289-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 136234.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-94008289-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.193 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ABCA4NM_000350.3 linkuse as main transcriptc.5844A>G p.Pro1948= synonymous_variant 42/50 ENST00000370225.4
ABCA4XM_047416704.1 linkuse as main transcriptc.5622A>G p.Pro1874= synonymous_variant 41/49

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ABCA4ENST00000370225.4 linkuse as main transcriptc.5844A>G p.Pro1948= synonymous_variant 42/501 NM_000350.3 P1
ABCA4ENST00000465352.1 linkuse as main transcriptn.260A>G non_coding_transcript_exon_variant 3/65

Frequencies

GnomAD3 genomes
AF:
0.193
AC:
29303
AN:
151902
Hom.:
2897
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.129
Gnomad FIN
AF:
0.172
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.185
Gnomad OTH
AF:
0.180
GnomAD3 exomes
AF:
0.173
AC:
43438
AN:
251288
Hom.:
3942
AF XY:
0.170
AC XY:
23135
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.239
Gnomad AMR exome
AF:
0.156
Gnomad ASJ exome
AF:
0.203
Gnomad EAS exome
AF:
0.127
Gnomad SAS exome
AF:
0.133
Gnomad FIN exome
AF:
0.174
Gnomad NFE exome
AF:
0.184
Gnomad OTH exome
AF:
0.175
GnomAD4 exome
AF:
0.179
AC:
261337
AN:
1459848
Hom.:
24144
Cov.:
33
AF XY:
0.178
AC XY:
128988
AN XY:
726322
show subpopulations
Gnomad4 AFR exome
AF:
0.247
Gnomad4 AMR exome
AF:
0.159
Gnomad4 ASJ exome
AF:
0.204
Gnomad4 EAS exome
AF:
0.136
Gnomad4 SAS exome
AF:
0.133
Gnomad4 FIN exome
AF:
0.176
Gnomad4 NFE exome
AF:
0.183
Gnomad4 OTH exome
AF:
0.177
GnomAD4 genome
AF:
0.193
AC:
29369
AN:
152020
Hom.:
2911
Cov.:
32
AF XY:
0.190
AC XY:
14129
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.238
Gnomad4 AMR
AF:
0.165
Gnomad4 ASJ
AF:
0.211
Gnomad4 EAS
AF:
0.131
Gnomad4 SAS
AF:
0.129
Gnomad4 FIN
AF:
0.172
Gnomad4 NFE
AF:
0.185
Gnomad4 OTH
AF:
0.185
Alfa
AF:
0.161
Hom.:
4193
Bravo
AF:
0.195
Asia WGS
AF:
0.158
AC:
550
AN:
3478
EpiCase
AF:
0.185
EpiControl
AF:
0.182

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:20Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 27, 2013- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 10, 2012This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 04, 2020The p.Pro1948Pro variant in ABCA4 is classified as benign because it does not alter an amino acid residue, is not located within the splice consensus site, and has been identified in 17.6% (49636/282614) of total chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1, BP4, BP7. -
not provided Benign:3Other:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 11, 2023- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Retinitis Pigmentosa, Recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Stargardt Disease, Recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Age related macular degeneration 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
ABCA4-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Severe early-childhood-onset retinal dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Cone-Rod Dystrophy, Recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Retinitis pigmentosa 19 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Cone-rod dystrophy 3 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Retinal dystrophy Benign:1
Benign, criteria provided, single submitterresearchDept Of Ophthalmology, Nagoya UniversityOct 01, 2023- -
Macular degeneration Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
2.1
DANN
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2275029; hg19: chr1-94473845; COSMIC: COSV64672034; COSMIC: COSV64672034; API